Trastuzumab (ELEFTHA)

In Stock

Trastuzumab (ELEFTHA) is a targeted therapy used for the treatment of HER2-positive breast cancer and metastatic gastric cancer. It works by specifically binding to the HER2 receptors on cancer cells, blocking their growth and promoting immune system response. This advanced monoclonal antibody therapy helps slow disease progression and improves survival outcomes. Doctors commonly prescribe it as part of combination therapy or as a standalone treatment depending on the stage of cancer. Known for its precision and effectiveness, this injection supports modern oncology care with reliable results and improved patient quality of life when administered under medical supervision.

Category: Oncology Medicines

Description
Specification

Description

Trastuzumab (ELEFTHA) delivers targeted therapy for patients diagnosed with HER2-positive breast cancer and metastatic gastric cancer. This advanced monoclonal antibody actively identifies and binds to HER2 receptors on cancer cells, blocking their growth signals and slowing tumor progression. Doctors rely on this treatment to improve survival outcomes and enhance treatment precision in modern oncology care.

This therapy strengthens the immune system by marking cancer cells for destruction. It actively prevents the uncontrolled multiplication of malignant cells while supporting healthier cell function. Physicians often include it in combination treatment plans with chemotherapy or use it as a standalone therapy based on the patient’s condition and disease stage.

Healthcare professionals administer this injection through intravenous infusion under controlled clinical settings. Medical teams carefully monitor each dose to ensure safety and effectiveness. This approach allows precise delivery and maximizes therapeutic benefits while minimizing risks.

Trastuzumab (ELEFTHA) supports long-term disease management by reducing recurrence risk and improving overall patient outcomes. Oncologists select this therapy because it directly targets cancer at the molecular level, offering a more focused and effective treatment approach than traditional therapies.

Patients benefit from its proven clinical performance and its ability to improve quality of life during treatment. This therapy plays a critical role in personalized cancer care, where doctors tailor treatments to specific biological markers.

Proper storage conditions between 2°C and 8°C maintain the stability and effectiveness of the injection. Medical professionals ensure correct handling to preserve its potency.

This targeted treatment continues to transform cancer care by offering precise action, reliable outcomes, and improved survival benefits for patients facing aggressive HER2-positive cancers.